Imugene Ltd
F:ILA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Imugene Ltd (ILA) under the Base Case is 0.05 EUR per share.
Compared with the current market price of 0.02 EUR, the stock appears
Undervalued by 58% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Imugene Does
Imugene Ltd is a biotechnology company that develops cancer immunotherapy drugs. Its main work is to design and test treatments that help the body’s immune system recognize and attack cancer cells. The company does not sell a broad portfolio of medicines; instead, it focuses on a pipeline of experimental therapies that are still in development and clinical testing.
- Headquarters
- Australia AU
- IPO date
- Dec 2, 1993
Earnings Waterfall
Imugene Ltd
What is the Intrinsic Value of one ILA stock?
The intrinsic value for Imugene Ltd (ILA) under the Base Case is 0.05 EUR.
Is ILA stock undervalued or overvalued?
Compared with the current market price of 0.02 EUR, the stock appears Undervalued by 58% .
